Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Palbociclib
Related studies linked through entity extraction aliases.
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
- Status
- COMPLETED
- Phase
- PHASE3
Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
To Reverse ENDocrine Resistance Trial - PD 0332991 Monotherapy vs PD 0332991 in Combination With the Endocrine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
- Status
- COMPLETED
- Phase
- PHASE2
PALbociclib CoLlaborative Adjuvant Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC
- Status
- COMPLETED
- Phase
- PHASE1
Palbociclib Pharmacokinetics Study In Postmenopausal Chinese Women With ER (+), HER2 (-) Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2